Richard D. Olson

16.0k total citations · 2 hit papers
140 papers, 10.7k citations indexed

About

Richard D. Olson is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Richard D. Olson has authored 140 papers receiving a total of 10.7k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Cellular and Molecular Neuroscience, 46 papers in Molecular Biology and 44 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Richard D. Olson's work include Neuropeptides and Animal Physiology (50 papers), Chemotherapy-induced cardiotoxicity and mitigation (30 papers) and Receptor Mechanisms and Signaling (28 papers). Richard D. Olson is often cited by papers focused on Neuropeptides and Animal Physiology (50 papers), Chemotherapy-induced cardiotoxicity and mitigation (30 papers) and Receptor Mechanisms and Signaling (28 papers). Richard D. Olson collaborates with scholars based in United States, Canada and Australia. Richard D. Olson's co-authors include Katrina L. Piercy, Janet E. Fulton, Deborah A. Galuska, Richard P. Troiano, Rachel Ballard, Stephanie M. George, Susan A. Carlson, Abba J. Kastin, Phillip S. Mushlin and Gayle A. Olson and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and JAMA.

In The Last Decade

Richard D. Olson

137 papers receiving 10.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Physical Activity Guidelines for Americans

2018 5.5k citations Richard D. Olson et al. profile →
Doxorubicin cardiotoxicity: analysis of prevailing hypotheses

1990 576 citations Richard D. Olson, Phillip S. Mushlin profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard D. Olson United States	39	3.5k	2.4k	2.3k	1.7k	1.5k	140	10.7k
Melville R. Klauber United States	64	4.2k 1.2×	1.6k 0.7×	1.3k 0.6×	1.5k 0.9×	911 0.6×	152	21.3k
Lon R. White United States	86	7.6k 2.1×	2.4k 1.0×	2.1k 0.9×	2.5k 1.4×	1.4k 0.9×	217	22.5k
Robert S. Sherwin United States	74	5.3k 1.5×	1.8k 0.8×	2.9k 1.3×	3.4k 2.0×	1.2k 0.8×	208	21.2k
Alan D. Kaye United States	61	2.3k 0.7×	2.2k 0.9×	2.0k 0.9×	1.8k 1.1×	1.2k 0.8×	1.1k	19.5k
James L. Howard Canada	42	1.8k 0.5×	3.6k 1.5×	1.9k 0.8×	1.6k 0.9×	1.3k 0.9×	243	16.6k
Joel Katz Canada	66	3.8k 1.1×	1.8k 0.7×	1.3k 0.6×	621 0.4×	1.0k 0.7×	332	19.5k
Kamal Masaki United States	73	5.6k 1.6×	2.5k 1.1×	2.0k 0.9×	1.7k 1.0×	643 0.4×	267	18.3k
Michael G. Ziegler United States	71	4.2k 1.2×	4.6k 1.9×	647 0.3×	3.0k 1.8×	2.2k 1.5×	407	17.0k
Gary Wittert Australia	74	6.1k 1.7×	2.2k 0.9×	3.3k 1.4×	1.6k 0.9×	521 0.4×	488	18.6k
Anton J.M. de Craen Netherlands	68	3.4k 1.0×	2.5k 1.0×	1.2k 0.5×	1.3k 0.8×	269 0.2×	298	16.6k

Countries citing papers authored by Richard D. Olson

Since Specialization

Citations

This map shows the geographic impact of Richard D. Olson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard D. Olson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard D. Olson more than expected).

Fields of papers citing papers by Richard D. Olson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard D. Olson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard D. Olson. The network helps show where Richard D. Olson may publish in the future.

Co-authorship network of co-authors of Richard D. Olson

This figure shows the co-authorship network connecting the top 25 collaborators of Richard D. Olson. A scholar is included among the top collaborators of Richard D. Olson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard D. Olson. Richard D. Olson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Trenhaile, Scott W., et al.. (2018). Glenohumeral osteoarthritis: frequency of underlying diagnoses and the role of arm dominance—a retrospective analysis in a community-based musculoskeletal practice. Rheumatology International. 38(6). 1023–1029. 9 indexed citations

Pennington, Bruce F., et al.. (2007). Brain Structure Correlates of Component Reading Processes: Implications for Reading Disability. Cortex. 43(6). 777–791. 15 indexed citations

Olson, Richard D., Hervé A. Gambliel, Robert E. Vestal, et al.. (2005). Doxorubicin Cardiac Dysfunction: Effects on Calcium Regulatory Proteins, Sarcoplasmic Reticulum, and Triiodothyronine. Cardiovascular Toxicology. 5(3). 269–284. 51 indexed citations

Cusack, Barry J., Beth Musser, Hervé A. Gambliel, Nicholas Hadjokas, & Richard D. Olson. (2003). Effect of dexrazoxane on doxorubicin pharmacokinetics in young and old rats. Cancer Chemotherapy and Pharmacology. 51(2). 139–146. 15 indexed citations

Gambliel, Hervé A., et al.. (2002). Doxorubicin and C-13 Deoxydoxorubicin Effects on Ryanodine Receptor Gene Expression. Biochemical and Biophysical Research Communications. 291(3). 433–438. 33 indexed citations

Cusack, Barry J., et al.. (2002). Effect of Aging on Cardiac Contractility in a Rat Model of Chronic Daunorubicin Cardiotoxicity. Cardiovascular Toxicology. 2(2). 99–110. 5 indexed citations

Soignier, R. Denis, James E. Zadina, Abba J. Kastin, et al.. (2000). Dissociation of analgesic and rewarding effects of endomorphin-1 in rats. Peptides. 21(12). 1871–1874. 70 indexed citations

Bell, Richard L., Anthony L. Vaccarino, Richard D. Olson, et al.. (1999). Tolerance and morphine-induced cross-tolerance are not shown to Tyr-W-MIF-1 analgesia. Peptides. 20(8). 971–978. 5 indexed citations

Cusack, Barry J., et al.. (1997). Age-related pharmacokinetics of daunorubicin and daunorubicinol following intravenous bolus daunorubicin administration in the rat. Cancer Chemotherapy and Pharmacology. 39(6). 505–512. 7 indexed citations

10.

Olson, Gayle A., et al.. (1994). The Tyr-MIF-1 family of peptides. Neuroscience & Biobehavioral Reviews. 18(4). 519–525. 23 indexed citations

11.

Cusack, Barry J., et al.. (1993). Daunorubicin-Induced Cardiac Injury in the Rabbit: A Role for Daunorubicinol?. Toxicology and Applied Pharmacology. 118(2). 177–185. 45 indexed citations

12.

Mushlin, Phillip S., et al.. (1993). Time‐related increases in cardiac concentrations of doxorubicinol could interact with doxorubicin to depress myocardial contractile function. British Journal of Pharmacology. 110(3). 975–982. 64 indexed citations

13.

Olson, Gayle A., Richard D. Olson, & Abba J. Kastin. (1992). Endogenous opiates: 1991. Peptides. 13(6). 1247–1287. 37 indexed citations

14.

Kastin, Abba J., et al.. (1992). Age- and Sex-Related Changes in Tyr-MIF-1-Like Immunoreactivity in Rat Plasma. Neuroendocrinology. 56(6). 902–906. 6 indexed citations

15.

Olson, Gayle A., Richard D. Olson, & Abba J. Kastin. (1990). Endogenous opiates: 1989. Peptides. 11(6). 1277–1304. 52 indexed citations

16.

Olson, Gayle A., et al.. (1989). MIF-1 is active in a chronic stress animal model of depression. Pharmacology Biochemistry and Behavior. 32(3). 737–742. 31 indexed citations

17.

Olson, Richard D., Dennis L. Stevens, & Marian E. Melish. (1989). Direct Effects of Purified Staphylococcal Toxic Shock Syndrome Toxin 1 on Myocardial Function of Isolated Rabbit Atria. Clinical Infectious Diseases. 11(Supplement_1). S313–S315. 18 indexed citations

18.

Olson, Gayle A., Richard D. Olson, & Abba J. Kastin. (1987). Endogenous opiates: 1986. Peptides. 8(6). 1135–1164. 29 indexed citations

19.

Boucek, Robert J., Marc E. Shelton, Michael Artman, et al.. (1984). Comparative Effects of Verapamil, Nifedipine, and Diltiazem on Contractile Function in the Isolated Immature and Adult Rabbit Heart. Pediatric Research. 18(10). 948–952. 54 indexed citations

20.

Gillner, Arnold, et al.. (1969). Intensive short-term rehabilitation of geriatric patientts. Intitial results and one-year follow up. Journal of Rehabilitation Medicine. 1(3). 133–138. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact